COVID-19 and the cardiovascular system
Top Cited Papers
- 5 March 2020
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 17 (5), 259-260
- https://doi.org/10.1038/s41569-020-0360-5
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through ACE2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, while also causing acute myocardial injury and chronic damage to the cardiovascular system. Therefore, particular attention should be given to cardiovascular protection during treatment for COVID-19.Keywords
This publication has 14 references indexed in Scilit:
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family clusterThe Lancet, 2020
- Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after InfectionScientific Reports, 2017
- Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2016
- Acute myocarditis associated with novel Middle East respiratory syndrome coronavirusAnnals of Saudi Medicine, 2016
- Sick sinus syndrome induced by interferon and ribavirin therapy in a patient with chronic hepatitis CJournal of Cardiology Cases, 2013
- Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generationNature, 2013
- ACE2: from vasopeptidase to SARS virus receptorTrends in Pharmacological Sciences, 2004
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology, 2004